Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ocean Springs, MS
NPI
1912950320
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3635 Bienville Blvd
Ocean Springs, MS, 39564
Phone (228) 872-1951
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
594 services
Medicare patients, 2024
303
Average age 74
Drug cost, 2024
$5.7M
2,247 prescriptions
Company payments, 2025
$1,270
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muzaffar Piracha was code 99214 (office e&m - established), 325 times for 216 patients. In total Muzaffar Piracha billed 594 services in 8 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 325 | 216 | $63.09 | $21K |
| 99215 Office E&M - Established | Office | 131 | 120 | $94.74 | $12K |
| 99213 Office E&M - Established | Office | 42 | 39 | $43.75 | $1,838 |
| 99205 Office E&M - New | Office | 39 | 39 | $126.64 | $4,939 |
| 10005 Other Organ Systems | Office | 25 | 24 | $46.65 | $1,166 |
| 99204 Office E&M - New | Office | 15 | 15 | $91.05 | $1,366 |
By year: 2022 $49K for 678 services; 2023 $43K for 610 services; 2024 $43K for 594 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muzaffar Piracha prescribed most often to Medicare patients was Levothyroxine Sodium, with 614 prescriptions and refills. In total Muzaffar Piracha wrote 2,247 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 614 | 1,666 | 171 | $5,797 |
| Ozempic Semaglutide | 147 | 197 | 21 | $179K |
| Synthroid Levothyroxine Sodium | 141 | 312 | 32 | $13K |
| Metformin Hcl Generic | 99 | 227 | 28 | $710 |
| Methimazole Generic | 95 | 198 | 24 | $955 |
| Alendronate Sodium Generic | 93 | 213 | 31 | $1,088 |
| Jardiance Empagliflozin | 78 | 158 | 21 | $84K |
| Strensiq Asfotase Alfa | 61 | 61 | Under 11 | $5.1M |
| Mounjaro Tirzepatide | 50 | 59 | Under 11 | $62K |
| Rosuvastatin Calcium Generic | 49 | 93 | Under 11 | $253 |
| Calcitriol Generic | 43 | 89 | 11 | $1,170 |
| Dexamethasone Generic | 41 | 43 | 25 | $84.66 |
| Glipizide Generic | 35 | 85 | 12 | $306 |
| Glimepiride Generic | 35 | 94 | 12 | $238 |
| Metformin Hcl Er Metformin Hcl | 34 | 70 | 12 | $274 |
Brand drugs: 1,073 claims; generic drugs: 1,072 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muzaffar Piracha $1,270 ($1,270 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbott Laboratories with $225.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 14 | $225 |
| Novo Nordisk Inc NVO | 14 | $213 |
| Renalytix AI, Inc. | 4 | $82.06 |
| Amgen Inc. AMGN | 4 | $76.76 |
| Beta Bionics, Inc. BBNX | 4 | $74.4 |
| Xeris Pharmaceuticals, Inc. | 3 | $68.8 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $62.78 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $48.04 |
| Corcept Therapeutics CORT | 2 | $39.66 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $38.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.